Nobilis Health Corp.
NRTSF · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Revenue | $300 | $286 | $229 | $84 |
| % Growth | 4.9% | 24.7% | 172.8% | – |
| Cost of Goods Sold | $113 | $110 | $78 | $23 |
| Gross Profit | $187 | $176 | $151 | $61 |
| % Margin | 62.4% | 61.6% | 65.9% | 72.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $151 | $157 | $111 | $38 |
| SG&A Expenses | $151 | $157 | $111 | $38 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7 | $3 | -$0 | -$1 |
| Operating Expenses | $162 | $166 | $116 | $40 |
| Operating Income | $22 | $10 | $32 | $21 |
| % Margin | 7.4% | 3.5% | 13.8% | 24.8% |
| Other Income/Exp. Net | $1 | $2 | $9 | -$1 |
| Pre-Tax Income | $23 | $12 | $41 | $20 |
| Tax Expense | $13 | $4 | -$23 | $13 |
| Net Income | $4 | $6 | $51 | $7 |
| % Margin | 1.3% | 2.3% | 22.2% | 8% |
| EPS | 0.05 | 0.08 | 0.76 | 0.14 |
| % Growth | -37.5% | -89.5% | 442.9% | – |
| EPS Diluted | 0.05 | 0.08 | 0.68 | 0.14 |
| Weighted Avg Shares Out | 78 | 76 | 67 | 47 |
| Weighted Avg Shares Out Dil | 78 | 78 | 75 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $4 | $2 | $0 |
| Depreciation & Amortization | $12 | $9 | $5 | $2 |
| EBITDA | $34 | $19 | $36 | $22 |
| % Margin | 11.4% | 6.7% | 15.9% | 26.2% |